United Therapeutics Corp
NASDAQ:UTHR
United Therapeutics Corp
NASDAQ:UTHR
Price:
272.69 USD
1.08%
Market Closed
Updated:
May 16, 2024
United Therapeutics Corp
EPS (Diluted)
|
United Therapeutics Corp
EPS (Diluted) Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
United Therapeutics Corp
NASDAQ:UTHR
|
EPS (Diluted)
$21
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$13
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$33
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
See Also
What is United Therapeutics Corp's EPS (Diluted)?
EPS (Diluted)
21.1
USD
21.1
USD
Based on the financial report for Mar 31, 2024, United Therapeutics Corp's EPS (Diluted) amounts to 21.1 USD.
What is United Therapeutics Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
17%
17%
Over the last year, the EPS (Diluted) growth was 44%. The average annual EPS (Diluted) growth rates for United Therapeutics Corp have been 34% over the past three years , and 17% over the past ten years .
You don't have any saved screeners yet
